Outcome of multidisciplinary treatment of peripheral primitive neuroectodermal tumor
Open Access
- 24 September 2020
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-9
Abstract
Peripheral primitive neuroectodermal tumors (PNETs) constitute very rare and aggressive malignancies. To date, there are no standard guidelines for management of peripheral PNETs due to the paucity of cases arising in various body sites. Therapeutic approach is derived from Ewing sarcoma family, which currently remains multimodal. Our study retrospectively analyzed 86 PNET patients from February 1, 1998 to February 1, 2018 at Peking Union Medical College Hospital with an additional 75 patients from review of literature. The clinicopathologic and treatment plans associated with survival was investigated. Surgery, chemotherapy, female sex, small tumor size, no lymph node metastasis, R0 surgical resection, (vincristine + doxorubicin + cyclophosphamide)/(isophosphamide + etoposide) regimen, and more than 10 cycles of chemotherapy were associated with improved overall survival in univariate analysis. Surgery, more than 10 cycles of chemotherapy, and small tumor size were independent prognostic factors for higher overall survival. Our data indicates that multimodal therapy is the mainstay therapeutic approach for peripheral PNET.Keywords
This publication has 46 references indexed in Scilit:
- Adult Ewing Sarcoma: Survival and Local Control Outcomes in 102 Patients with Localized DiseaseSarcoma, 2013
- Primary spinal extradural Ewing′s sarcoma (primitive neuroectodermal tumor): Report of a case and meta-analysis of the reported cases in the literatureSurgical Neurology International, 2012
- Chest Wall Ewing Sarcoma Family of Tumors: Long-Term OutcomesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Ewing sarcoma/primitive neuroectodermal tumor arising from the adrenal gland in an adolescentPediatric Blood & Cancer, 2011
- Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocolAnnals of Oncology, 2010
- Dose-Intensified Compared With Standard Chemotherapy for Nonmetastatic Ewing Sarcoma Family of Tumors: A Children's Oncology Group StudyJournal of Clinical Oncology, 2009
- Surgical Treatment and Prognosis of Primitive Neuroectodermal Tumors of the ThoraxJournal of Thoracic Oncology, 2009
- Favorable outcome of Ewing sarcoma family tumors to multiagent intensive preoperative chemotherapy: A single institution experienceJournal of Surgical Oncology, 2005
- Treatment of Ewing sarcoma family of tumors: Current status and outlook for the futureMedical and Pediatric Oncology, 2003
- Primary Ewing's Sarcoma/Primitive Neuroectodermal Tumor of the KidneyAmerican Journal of Surgical Pathology, 2002